The inhibitor and substrate compete for the same binding site (or the active site) on the enzyme. The inhibitor decreases the enzyme’s capacity to bind the substrate, but this impact may be ...

Nitrogen, upon which all life on Earth depends, may hold the key for explaining how early life on the planet evolved and how it could evolve on other planets. "All living organisms need nitrogen to ...

ABSTRACT: Rhodanese plays a critical role in cyanide detoxification by catalyzing the conversion of toxic cyanide into the less harmful thiocyanate. This comprehensive review examines recent studies ...

ABSTRACT: Rhodanese plays a critical role in cyanide detoxification by catalyzing the conversion of toxic cyanide into the less harmful thiocyanate. This comprehensive review examines recent studies ...

Substrate, a small San Francisco startup is making waves in the global semiconductor industry, a business widely believed too complex to break into. With its proprietary technology, Substrate emerges ...

CHAMPAIGN, Ill. — A new artificial intelligence-powered tool can help researchers determine how well an enzyme fits with a desired target, helping them find the best enzyme and substrate combination ...

Abstract: Enzymes play a critical role in catalyzing biochemical reactions, and accurately predicting their substrate specificity is essential for applications in drug discovery, metabolic engineering ...

In a new paper, scientists have reported the first successful human transplant of a kidney converted from blood type A to the universal type O using special enzymes developed at the University of ...

Using artificial intelligence, researchers show how γ-secretase recognizes substrates - an important advance for fundamental and translational research. The γ-secretase enzyme is capable of cleaving ...

Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

Amplifye, a UC Davis spinout led by former Amyris CEO John Melo, has launched its first product: a proprietary enzyme (P24) claimed to optimize protein digestion, unlocking a range of health benefits ...